344 results on '"Matsuda, Toshiaki"'
Search Results
2. Interstitial pneumonia with autoimmune features and histologic usual interstitial pneumonia treated with anti-fibrotic versus immunosuppressive therapy
3. Idiopathic Pulmonary Fibrosis Incidentally Detected by CT Scan as Interstitial Lung Abnormalities
4. The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease
5. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease
6. Pulmonary rehabilitation for idiopathic pleuroparenchymal fibroelastosis: A retrospective study on its efficacy, feasibility, and safety
7. Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis
8. Pulse oximetry saturation can predict prognosis of idiopathic pulmonary fibrosis
9. Predictive factors for the recurrence of anti-aminoacyl-tRNA synthetase antibody-associated interstitial lung disease
10. Usefulness of new diagnostic criteria for chronic hypersensitivity pneumonitis established on the basis of a Delphi survey: A Japanese cohort study
11. Prediction of survival in patients with pulmonary hypertension associated with interstitial lung disease treated with pulmonary vasodilators
12. Preclinical idiopathic pulmonary fibrosis (IPF): a retrospective cohort study
13. Early intervention of antifibrotics along with anti-inflammatory treatment in rapidly progressive interstitial lung disease (RP-ILD) with anti-MDA5 antibody-positive dermatomyositis (MDA5-DM)
14. Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities.
15. Performance of the COPD Assessment Test in patients with connective tissue disease-associated interstitial lung disease
16. Longitudinal changes in pulmonary function and respiratory impedance of rheumatoid arthritis
17. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis
18. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
19. Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
20. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
21. Physical activity in idiopathic pulmonary fibrosis: Longitudinal change and minimal clinically important difference
22. Two cases of acute respiratory failure following SARS‐CoV ‐2 vaccination in post‐ COVID ‐19 pneumonia
23. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype
24. Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system
25. Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer
26. Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
27. Seven of eight species in Nicotiana section Suaveolentes have common factors leading to hybrid lethality in crosses with Nicotiana tabacum
28. Possible involvement of genes on the Q chromosome of Nicotiana tabacum in expression of hybrid lethality and programmed cell death during interspecific hybridization to Nicotiana debneyi
29. Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
30. Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis
31. New Guideline Diagnosis of Fibrotic Hypersensitivity Pneumonitis in Idiopathic Pulmonary Fibrosis
32. Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
33. Cutoff Points for Step Count to Predict 1-year All-Cause Mortality in Patients with Idiopathic Pulmonary Fibrosis
34. Effects of Interval Exercise in Interstitial Lung Disease Patients: PS198
35. Effects of In-Patient Pulmonary Rehabilitation for Advanced Idiopathic Pulmonary Fibrosis: PS199
36. The Benefits of Pulmonary Rehabilitation in COPD; Examination by a New Gold Classification: PS194
37. COPD Assessment Test as a Predictive Factor of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: PS158
38. Prognostic Significance of Lung-dominant CTD on Usual Interstitial Pneumonia: OS134
39. Health-Related Quality of Life Impacts on Survival in Idiopathic Pulmonary Fibrosis: OS103
40. Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation
41. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
42. Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?
43. Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation
44. Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status
45. The health status in idiopathic pleuroparenchymal fibroelastosis
46. The starch-debranching enzymes isoamylase and pullulanase are both involved in amylopectin biosynthesis in rice endosperm (1)
47. Expression Patterns of Genes Encoding Carbohydrate-metabolizing Enzymes and their Relationship to Grain Filling in Rice (Oryza sativa L.): Comparison of Caryopses Located at Different Positions in a Panicle
48. Development of a Novel Polyimide Hollow-fiber Oxygenator
49. At Least Thirty-Four Days of Animal Continuous Perfusion by a Newly Developed Extracorporeal Membrane Oxygenation System without Systemic Anticoagulants
50. Acute exacerbations of fibrotic interstitial lung diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.